‘COVID-19 is India’s chance to scale up API production’
Pharma industry leaders on Tuesday said the COVID-19 outbreak and the resulting pressure it has brought on the raw material imports from China should be viewed as an opportunity to scale up domestic production of active pharmaceutical ingredients (APIs). Speaking at a CEO’s Conclave at BioAsia 2020, Indian Pharmaceutical Alliance president and Dr. Reddy’s Laboratories … Read more